<DOC>
	<DOCNO>NCT00960037</DOCNO>
	<brief_summary>This study extension earlier study vitamin D supplementation conduct normal weight individual Dr. John Aloia Bone Mineral Research Division Winthrop University Hospital . The investigator plan compare response vitamin D supplementation obese individual response already measure normal weight individual . The dosing schedule vitamin supplementation use past . The dos use past demonstrated safety number trial , Winthrop well outside Winthrop Hospital . Sixty study volunteer plan enrollment study . The study participant mainly recruit group patient past enrolled weight loss program Winthrop Hospital . Each participant vitamin D supplementation total 8 week . Vitamin D blood level measure end supplementation period . They compare see change time result supplementation .</brief_summary>
	<brief_title>Trial Assess Response Oral Vitamin D3 Supplementation Obese Individuals</brief_title>
	<detailed_description />
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>obese adult age 1865 year BMI &gt; 35 chronic medical illness ( diabetes , malignancy , uncontrolled hypertension , kidney disease ) subject undergone bariatric surgery currently enrol medically supervised weight loss program BMI &lt; 35 pregnancy use medication influence vitamin D metabolism history hypercalcemia , hypercalciuria , nephrolithiasis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Vitamin D3</keyword>
	<keyword>obesity</keyword>
	<keyword>cholecalciferol</keyword>
</DOC>